Nokia and Celesta Capital Collaborate to Launch Astranu
In an exciting collaboration aimed at revolutionizing healthcare imaging technology, Nokia has partnered with Celesta Capital to introduce Astranu. This innovative company will focus on commercializing advanced imaging systems that promise to dramatically improve ear diagnostics.
Transforming the Hearing Care Landscape
Astranu’s technology is based on the highly sophisticated integrated Optical Coherence Tomography (iOCT) developed at Nokia Bell Labs. This state-of-the-art imaging system is designed to offer rapid and accurate 3D imaging for diagnosing middle-ear conditions and analyzing hearing responses. The innovation is poised to fill critical gaps in healthcare by addressing issues often associated with misdiagnosis and the dependence on expensive and invasive imaging methods.
A Major Breakthrough in Ear Diagnostics
The proprietary iOCT technology changes the way ear diagnostics are performed by providing affordable, non-invasive, high-resolution imaging. This could lead to significant reductions in unnecessary referrals and invasive exploratory surgeries that are often required with traditional imaging techniques like CT and MRI scans.
Leadership Driving Astranu Forward
At the helm of Astranu is Trevor Hawkins, PhD, an experienced executive in healthcare technology. His leadership is crucial as the company ventures into the market with groundbreaking technology. Supporting him are the co-inventors of iOCT, Michael Eggleston, PhD, and Bibek Samanta, PhD, who played integral roles in developing this technology to its current state ready for commercial launch.
The Support of Nokia Bell Labs
Nokia Bell Labs will continue to play a vital role in Astranu’s journey by offering laboratory resources and R&D support, reaffirming Nokia’s commitment to fostering innovations that have a substantial impact on real-world applications.
The Role of Celesta Capital
Celesta Capital's involvement goes beyond funding; it provides strategic direction and vital industry connections to enable Astranu's technology to gain rapid market acceptance. Sriram Viswanathan, Founding Managing Partner at Celesta Capital, underscores the synergy between innovative technology and impactful healthcare solutions as a driving force behind this venture.
Board of Directors and Strategic Vision
Joining the board is Achin Bhowmik, PhD, Chief Technology Officer at Starkey, a leading hearing technology company. Dr. Bhowmik emphasizes the importance of Astranu’s imaging technology in delivering high-resolution insights at the point of care, promising to enhance patient outcomes significantly.
About Nokia and Celesta Capital
Nokia continues to lead in pioneering technologies that seamlessly enhance communication and operational frameworks globally. As a B2B technology innovator, its longstanding research through Nokia Bell Labs strengthens its capabilities to deliver secure and sustainable network solutions.
Meanwhile, Celesta Capital stands as a prominent deep technology venture capital firm, known for its strategic investments in technology-driven startups, nurturing them towards scalable success. They bring invaluable experience and support essential for early-stage companies aiming at going to market.
Frequently Asked Questions
What is Astranu's primary focus?
Astranu aims to revolutionize healthcare diagnostics through innovative imaging technology, particularly for ear-related conditions.
Who leads Astranu?
The company is led by Trevor Hawkins, PhD, a seasoned healthcare technology executive.
What technology does Astranu utilize?
Astranu employs integrated Optical Coherence Tomography (iOCT), developed at Nokia Bell Labs, for high-resolution imaging.
How does Astranu benefit healthcare?
Its technology offers a cost-effective and non-invasive alternative to traditional imaging, aiming to reduce misdiagnoses and unnecessary surgeries.
What support does Nokia provide to Astranu?
Nokia Bell Labs will offer laboratory resources and R&D support, contributing to Astranu’s innovation journey.
